NEW YORK, NY / ACCESSWIRE / February 05, 2016 / Beat the market by entering your email here http://valuableinvestment.com/ and get the pros pick to consistently outperform the market!
ValuableInvestment.com and its team conduct endless hours of due-diligence on stocks to find opportunities to make money for its members. We alert our investor community of daily trades and provide solid technical results producing gains for our readers.
Find out right now how to increase your portfolios annual return by signing up here http://valuableinvestment.com/register
We have uncovered several great stocks ahead of today's session: Steris PLC (NYSE: STE), Wright Medical Group N.V. (NASDAQ: WMGI), Nxstage Medical Inc. (NASDAQ: NXTM), and NuVasive Inc. (NASDAQ: NUVA). Trade strategy on Steris can be accessed at http://valuableinvestment.com/STE.
On Thursday, February 04, 2016, the NASDAQ Composite ended at 4,509.56, up 0.12%, the Dow Jones Industrial Average advanced 0.49%, to finish the day at 16,416.58, and the S&P 500 closed at 1,915.45, up 0.15%. The gains were broad based as five out of nine sectors ended the session in positive. Register for your complimentary reports at the links given below:
http://valuableinvestment.com/signup
On Thursday, shares in Steris PLC ended the session 0.38% lower at $68.66. The stock reported a trading volume of 0.94 million shares, above its three months average volume of 0.86 million shares. Shares of the company traded at a PE ratio of 36.72. Steris PLC's shares have advanced 3.73% in the past one year, but the stock has declined 7.58% in the last one month. The company is trading 0.48% above its 200-day moving average. Moreover, shares of Steris PLC have a Relative Strength Index (RSI) of 42.83. Sign up and read the alert on STE at:
http://valuableinvestment.com/STE
Wright Medical Group N.V.'s stock plummeted 6.42%, to close the day at $18.81. The stock recorded a trading volume of 1.37 million shares, much above its three months average volume of 0.78 million shares. The company's shares are trading 14.66% below their 50-day moving average. Additionally, Wright Medical Group N.V. has an RSI of 33.41. The complimentary trade alert on WMGI can be turned on at:
http://valuableinvestment.com/WMGI
On Thursday, shares in Nxstage Medical Inc. recorded a trading volume of 0.40 million shares, lower than their three months average volume of 0.55 million shares. The stock ended the day 2.59% lower at $19.16. Nxstage Medical Inc.'s stock has lost 8.89% in the last one month, but it has advanced 0.31% in the previous three months and 8.37% in the last one year. The company is trading above its 200-day moving average by 10.06%. Furthermore, shares of Nxstage Medical Inc. have an RSI of 44.92. Register for free on ValuableInvestment.com and access key information on NXTM at:
http://valuableinvestment.com/NXTM
NuVasive Inc.'s stock finished Thursday's session 0.45% lower at $44.43. A total of 0.39 million shares were traded, which was below its three months average volume of 0.48 million shares. The company's shares are trading below their 50-day and 200-day moving averages by 12.24% and 11.34%, respectively. NuVasive Inc.'s stock traded at a PE ratio of 36.72 and has an RSI of 31.59. NUVA alerts are available for free at:
http://valuableinvestment.com/NUVA
--
About ValuableInvestment.com:
Valuable Investment was founded in 2006 and has been successfully alerting investors and shareholders of the most profitable ways to earn a living on Wall Street. A decade is a very long time so we must be doing something right. We encourage everyone to come and try our strategy and see how we have been changing the foundation of research for years.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer and the Sponsor have not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author, the Reviewer, or the Sponsor (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein.
NO WARRANTY
ValuableInvestment.com, the Author, the Reviewer and the Sponsor (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither valuableinvestment.com nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://valuableinvestment.com/
RESTRICTIONS
ValuableInvestment.com is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
E-mail: press@valuableinvestment.com
SOURCE: ValuableInvestment.com
